A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients

[21] Kitchen J(2011)Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis Arch Dermatol 147 790-113.e2

[22] Chan A-W(2015)Cutaneous malignant melanoma in the Swedish organ transplantation cohort: a study of clinicopathological characteristics and mortality J Am Acad Dermatol 73 106-65

[23] Han W(2015)Melanoma risk and survival among organ transplant recipients J Invest Dermatol 135 2657-12

[24] Soltani K(2016)Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013 J Am Acad Dermatol 75 106-17

[25] Ming M(2008)Outcomes of melanoma in recipients of solid organ transplant J Am Acad Dermatol 59 405-75

[26] He Y-Y(2014)Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study Am J Transplant 14 1368-42

[27] Vajdic CM(2019)Survival after a cancer diagnosis among solid organ transplant recipients in the United States Cancer 125 933-40

[28] McDonald SP(2003)Immunosuppressive drugs and cancer Toxicology 185 229-80

[29] McCredie MRE(2006)An appraisal of tolerance in liver transplantation Am J Transplant 6 1774-82

[30] Marshall JA(2004)Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation Transplantation 77 1777-undefined

[21] Kitchen J(2011)Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis Arch Dermatol 147 790-113.e2

[22] Chan A-W(2015)Cutaneous malignant melanoma in the Swedish organ transplantation cohort: a study of clinicopathological characteristics and mortality J Am Acad Dermatol 73 106-65

[23] Han W(2015)Melanoma risk and survival among organ transplant recipients J Invest Dermatol 135 2657-12

[24] Soltani K(2016)Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013 J Am Acad Dermatol 75 106-17

[25] Ming M(2008)Outcomes of melanoma in recipients of solid organ transplant J Am Acad Dermatol 59 405-75

[26] He Y-Y(2014)Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study Am J Transplant 14 1368-42

[27] Vajdic CM(2019)Survival after a cancer diagnosis among solid organ transplant recipients in the United States Cancer 125 933-40

[28] McDonald SP(2003)Immunosuppressive drugs and cancer Toxicology 185 229-80

[29] McCredie MRE(2006)An appraisal of tolerance in liver transplantation Am J Transplant 6 1774-82

[30] Marshall JA(2004)Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation Transplantation 77 1777-undefined